BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21719159)

  • 1. Frontal meningioma on 99mTc-MIBI scan for postoperative evaluation of differentiated thyroid cancer.
    Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):320-1. PubMed ID: 21719159
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metastasizing follicular thyroid carcinoma with intracranial iodine 131 uptake in brain edema due to a frontal meningioma].
    Schmidt M; Scheidhauer K; Urbannek V; Luyken C; Friese M; Voth E; Schicha H
    Nuklearmedizin; 2000; 39(1):38-9. PubMed ID: 10726256
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental detection of a falx meningioma on post-therapy radioiodide whole-body imaging.
    Sinha P; Conrad GR; Holzhauer M
    Clin Nucl Med; 2002 Dec; 27(12):916-7. PubMed ID: 12607886
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of Hurthle cell carcinoma using sestamibi.
    Chamnanrabiabkij E; Welch A; Jayapaul MK; Perros P
    Thyroid; 2008 May; 18(5):575-6. PubMed ID: 18044993
    [No Abstract]   [Full Text] [Related]  

  • 6. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyrotoxicosis: a rare presenting symptom of Hurthle cell carcinoma of the thyroid.
    Wong CP; AuYong TK; Tong CM
    Clin Nucl Med; 2003 Oct; 28(10):803-6. PubMed ID: 14508269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism in patients treated for non-medullary thyroid carcinoma].
    Rubello D; Pagetta C; Pelizzo MR; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):31-4. PubMed ID: 11323565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
    Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
    J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidental finding of a meningioma-en-plaque in a patient with prostate adenocarcinoma].
    Cotrina Monroy AP; López López A; Ruiz Solis S; Gómez Embuena A
    Rev Esp Med Nucl; 2010; 29(5):254-7. PubMed ID: 20398966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-MIBI in differentiated thyroid carcinoma.
    Roelants V; Beckers C
    J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
    [No Abstract]   [Full Text] [Related]  

  • 13. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hürthle cell adenoma: false positive in (99m)Tc-sestamibi hyperparathyroidism study].
    Morera Ocón FJ; Sales Maicas MA; García-Granero Ximénez M; Agramunt Lerma M
    Med Clin (Barc); 2009 Jun; 133(3):118-9. PubMed ID: 19539827
    [No Abstract]   [Full Text] [Related]  

  • 16. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(99m)Tc-MIBI SPECT in the study of brain lymphoma].
    Mena LM; Martín F; Bravo C; Santos AB; Escabia MV; Jiménez IR
    Rev Esp Med Nucl; 2011; 30(6):380-1. PubMed ID: 21601963
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical value of 99mTc-MIBI imaging, 131I whole body scan and HTG determination for the follow-up of patients with differentiated thyroid carcinoma after 131I therapy].
    Yu N; Guan C; Liu Y; Yang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):437-9. PubMed ID: 11387963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer.
    Campennì A; Violi MA; Ruggeri RM; Sindoni A; Moleti M; Vermiglio F; Baldari S
    Nucl Med Commun; 2010 Apr; 31(4):274-9. PubMed ID: 20087239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.